Millions more adults should consider starting cholesterol-lowering medications earlier to reduce their risk of heart attack ...

Non-alcoholic fatty liver disease is on the rise and mainly stems from metabolic dysfunction. Dr Sood shares five facts about ...

Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...

Also, for the first time, doctors are advised to test for two biomarkers in the blood that have been linked to increased risks of heart disease.

Convenient, tasty AND good for your heart? Yes, please!

The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated guideline for the management of dyslipidemia-abnormal ...

Healthy lifestyle habits, earlier treatment to lower long-term exposure to plaque-causing lipids, new cholesterol target goals, selective use of coronary ...

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the ...

This week, Mad in America examines three studies around mental health diagnosis, psychotropic drug use, obesity, and diabetes ...

Fatty fish, like salmon, herring, and sardine, provide omega-3 fatty acids, crucial for heart and brain health. The body can't make these fats, so you will need to get them from your diet.

HT-VA restores cholesterol to control-diet levels and maintains lower triglycerides compared with semaglutide in western diet-fed female mice Treatment preserved hepatic ...